HIV & smoking in India

Indian Journal of Medical Research

Volumn 130, Issue 1, 2009, Pages 15-22

  Ramesh Kumar, S ^a   Swaminathan, Soumya ^a   Flanigan, Timothy ^b   Mayer, K H ^b   Niaura, Raymond ^b  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b BROWN UNIVERSITY   (United States)

Author keywords

HIV; India; Smoking cessation; Tobacco; Tuberculosis

Indexed keywords

AMFEBUTAMONE; ANTIRETROVIRUS AGENT; CLONIDINE; EFAVIRENZ; NICOTINE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; PLACEBO; PROTEINASE INHIBITOR; VARENICLINE;

AGE; BACTERIAL PNEUMONIA; CAUSAL ATTRIBUTION; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INDIA; INFECTION RISK; LEUKOPLAKIA; LUNG CAVITATION; MOUTH LESION; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PATIENT COUNSELING; PERIODONTAL DISEASE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SIDE EFFECT; SINUSITIS; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING HABIT; THRUSH; TOBACCO DEPENDENCE; TREATMENT DURATION; TUBERCULOSIS;

COMORBIDITY; HEALTH EDUCATION; HIV INFECTIONS; HUMANS; INDIA; SMOKING; SMOKING CESSATION; TUBERCULOSIS;

EID: 70349532818     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. WHO Framework Convention on Tobacco Control: why is it important? Available at: http://www.who.int/topics/tobacco/qa/en/, accessed on December 10, 2007.
2. International Policy Conference on Children and Tobacco. World Health Organization. Available at: http://www.who.int/directorgeneral/ speeches/1999/english/19990318_international_policy_conference.html, accessed on December 10, 2007.
3. Centers for Disease Control and Prevention. Health Effects of Cigarette Smoking. Available at: http://www.cdc.gov/tobacco/data_statistics/ fact-sheets/health_effects.cig.smoking/index. htm, accessed on May 30, 2008.
4. Rebanal RD, Leman R. Collaboration between Oregon's Chronic Disease Programs and Medicaid to decrease smoking among Medicaid-insured Oregonians with asthma. Prev Chronic Dis 2005; 2 Special issue: A12.
5. Centers for Disease Control and Prevention. Smoking & Tobacco use: Health effects. Available at: http://www.cdc.gov/tobacco/ basic-information/health_effects/index.htm, accessed on May 30, 2008.
6. Centers for Disease Control and Prevention. Smoking & Tobacco use: Health effects. Available at http://www.cdc.gov/tobacco/ basic-information/health_effects/index.htm, accessed on May 30, 2008.
7. Shimkhada R, Peabody JW. Tobacco control in India. Avaialable at: http://whqlibdoc.who.int/bulletin/2003/Vol81- No1/ bulletin_2003_81(1)_48-52.pdf, accessed on December 10, 2007.
8. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. the impact of cigarette smoking on mortality, quality of life and comorbid illness among HIV positive veterans. J Gen Int Med 2005; 20: 1142-5.
9. http://www.nfhsindia.org/volume_1.html, accessed on May 30, 2008.
10. Centers for Disease Control and Prevention. http://www.cdc. gov/ tobacco/data§atistics/fact_sheets/tobacco_industry/ bidis_kreteks.htm, accessed on May 30, 2008.
11. http://www.nfhsindiaorg/data/india/indch2.pdf, accessed on May 30, 2008.
12. Jindal SK, Agarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, et al. Tobacco smoking in India: prevalence, quit-rates and respiratory morbidity. Indian J Chest Dis Allied Sci 2006; 48: 37-42.
13. Singh VV, Singh Z, Banerjee A, Basannar DR. Determinants of smoking habit among medical students. Med J Armed Forced India 2003; 59: 209-11.
14. Banerjee A. Tobacco use patterns among military recruits. Med J Armed Forces India 2000; 56: 192-4.
15. Jindal SK, Aggarwal AN, Gupta D, Kashyap S, Chaudhary D. Prevalence of tobacco use among school going youth in North Indian states. Indian J Chest Dis Allied Sci 2005; 47: 161-6.
16. Gajalakshmi V, Asma S, Warren CW. Tobacco survey among youth in South India. Asian Pac J Cancer Prev 2004; 5: 273-8.
17. Sinha DN, Gupta PC, Pednekar MS. Tobacco use in rural area of Bihar, India. Indian J Commun Med 2003; 28: 167-70.
18. http://www.nacoonline.org/, NACO, accessed on April 11, 2008.
19. Tumbarello M, Tacconelli E, de Gaetano K, Ardito F, Pirronti T, Cauda R, et al. Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 39-45.
20. Wewers MD, Diaz PT, Wewers ME, Lowe MP, Nagaraja HN, Clanton TL. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 1998; 158: 1543-9.
21. Twigg HL 3rd, Soliman DM, Spain BA. Impaired alveolar macrophage accessory cell function and reduced incidence of lymphocytic alveolitis in HIV-infected patients who smoke. AIDS 1994; 8: 611-8.
22. Miguez-Burbano MJ, Ashkin D, Rodriguez A, Duncan R, Pitchenik A, Quintero N, et al. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease. Int J Infect Dis 2005; 9: 208-17.
23. Diaz PT, Wewers MD, Pacht E, Drake J, Nagaraja HN, Clanton TL. Respiratory symptoms among HIV-seropositive individuals. Chest 2003; 123: 1977-82.
24. Flanigan TP, Hogan JW, Smith D, Schoenbaum E, Vlahov D, Schuman P, et al. Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clin Infect Dis 1999; 29: 608-12.
25. Powles T, Nelson M, Bower M. HIV-related lung cancer - a growing concern? Int J STD AIDS 2003; 11: 647-51.
26. Spano JP, Massiani MA, Bentata M, Rixe O, Friard S, Bossi P, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol 2004; 21: 109-15.
27. Phelps RM, Smith DK, Heilig CM, Gardner LI, Carpenter CC, Klein RS, et al. HER Study Group. Cancer incidence in women with or at risk for HIV. Int J Cancer 2001; 94: 753-7.
28. Beck JD, Slade GD. Epidemiology of periodontal diseases. Curr Opin Periodontol 1996; 3: 3-9.
29. Conley L, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS 1996; 10: 1121-6.
30. Boulter AW, Soltanpoor N, Swan AV, Birnbaum W, Johnson NW, Teo CG. Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV infected individuals. AIDS 1996; 10: 935-40.
31. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigaratte smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Human Retroviral 1997; 14: 338-42.
32. Metersky M, Colt HG, Olson LK, Shanks TG. AIDS-related spontaneous pneumothorax. Risk factors and treatment. Chest 1995; 108: 946-51.
33. Feldman JG, Chirgwin K, Dehovitz AJ, Minkoff H. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 1997; 89: 346-50.
34. Burns DN, Landesman S, Muenz LR, Nugent RP, Goedert JJ, Minkoff H, et al. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J Acquir Immune Defic Syndr 1994; 7: 718-26.
35. Sherman CB. The health consequences of cigarette smoking. Pulmonary disease. Med Clin North Am 1992; 76: 355-75.
36. Nieman RB, Fleming J, Coker RJ. Harris JR, Mitchelle DM. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993; 7: 705-10.
37. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era - a report from the women's interagency HIV Study. Am J Public Health 2006; 96: 1060-5.
38. Furber AS, Maheshwaran R, Newell JN, Carroll C. Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systematic review. Sex Transm Infect 2007; 83: 41-6.
39. Duval X, Baron G, Garelik D, Villes V, Dupre T, Leport C, et al. Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther 2008; 13: 389-97.
40. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tobacco Res 2008; 10: 731-6.
41. Arday D, Edlin B, Giovino G, Nelson D. Smoking, HIV infection, and gay men in the United States. Tob Control 1993; 2: 156-8.
42. Niaura R, Shadel WG, Morrow K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS and smoking cessation: the time is now. Clin Infect Dis 2000; 31: 808-12.
43. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002; 57: 964-6.
44. Altet-Gomez MN, Alcaide J, Godoy P, Romero MA, Hernandez del Rey I. Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis 2005; 9: 430-6.
45. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in south India. Int J Tuberc Lung Dis 2005; 9: 556-61.
46. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003; 362: 507-15.
47. Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 2005; 34: 1395-402.
48. Boelaert JR, Gomes MS, Gordeuk VR. Smoking, iron and tuberculosis. Lancet 2003; 362: 1243-4.
49. http://www.surgeongeneral.gov/tobacco/treating_tobacco_use. pdf, accessed on December 12, 2007.
50. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3): CD000146.
51. Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction 2005; 100: 247-54.
52. Fagerstrom KO, Tejding R, Westin A, Lunell E. Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker? Tobacco Control 1997; 6: 311-6.
53. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685-91.
54. Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 2006; 166: 1571-7.
55. Nakamura M, Oshima A, Fujimoto Y, Maruyama N, Ishibashi T, Reeves KR. Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers. Clin Ther 2007; 29: 1040-56.
56. Demers RY, Neale AV, Adams R, Trembath C, Herman SC. The impact of physicians' brief smoking cessation counseling: a MIRNET study. J Fam Pract 1990; 31: 625-9.
57. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3) CD000146.
58. Ockene JK, Kristeller J, Goldberg R, Amick TL, Pekow PS, Hosmer D, et al. Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial. J Gen Intern Med 1991; 6: 1-8.
59. Swan GE, McAfee T, Curry SJ, Jack LM, Javitz H, Dacey S, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med 2003; 163: 2337-44.
60. Kumar R, Kushwah AS, Mahakud GC, Prakash S, Vijayan VK. Smoking cessation interventions and continuous abstinence rate at one year. Indian J Chest dis Allied Sci 2007; 49: 201-7.
61. Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, et al. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med 2006; 166: 1561-8.
62. Keating GM, Siddiqui MA. Varenicline: a review of its use as an aid to smoking cessation therapy. CNS Drugs 2006; 20: 945-60.
63. Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. J Clin Pharmacol 2006; 46: 991-8.
64. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nocotine Tobacco Res 2005; 7: 511-22.
65. Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 2007; 21: 458-68.
66. Lemstra M, Neudorf C, Opondo J. Implications of a public smoking ban. Can J Public Health 2008; 99: 62-5.